Care Ratings Q2 FY27 Results: Consolidated Net Profit ₹72.37 Crore on Total Income of ₹180 Crore
Earnings
credit rating services
Blacklitt Research3 min read
Care Ratings (NSE: CARERATING) reported consolidated total income of ₹179.56 crore and net profit of ₹72.37 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹150.41 crore and net profit of ₹69.16 crore, it said in a filing on 29 Oct 2026.
Key highlights
Consolidated
Including its subsidiaries
Total income: ₹179.56 crore, up 20.6% YoY and 42.0% QoQ
Net profit and EPS: ₹72.37 crore, up 26.5% YoY; basic EPS ₹23.88
Other income: ₹15.43 crore, 8.6% of total income
Interim dividend: ₹10 per share, record date 6 Nov 2026
Standalone
The company on its own, without its subsidiaries
Total income: ₹150.41 crore, up 18.6% YoY and 44.9% QoQ
Net profit and EPS: ₹69.16 crore, up 23.9% YoY; basic EPS ₹22.98
Other income: ₹16.20 crore, 10.8% of total income
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
179.56
148.95
+20.6%
126.48
+42.0%
Revenue from operations
164.13
136.37
+20.4%
111.68
+47.0%
Other income
15.43
12.58
+22.7%
14.80
+4.3%
72.37
57.21
+26.5%
32.99
+119.4%
Finance costs
0.58
0.61
-4.9%
0.60
-3.3%
Depreciation
3.86
3.46
+11.6%
3.86
0.0%
Tax expense
23.23
19.70
+17.9%
11.98
+93.9%
Net profit margin
40.30%
38.41%
+1.90 pp
26.08%
+14.22 pp
Tax as share of profit before tax
24.3%
25.6%
-1.32 pp
26.6%
-2.34 pp
EPS, basic (₹)
23.88
18.90
+26.3%
10.73
+122.6%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit grew faster than total income. Net profit rose 26.5% YoY to ₹72.37 crore while total income rose 20.6%, and profit before tax of ₹95.60 crore was up 24.3% on the year-earlier quarter's ₹76.91 crore. Tax took 24.3% of profit before tax, against 25.6% a year earlier.
Other income is a large part of the result. At ₹15.43 crore it grew 22.7% YoY, faster than revenue from operations at 20.4%, and equals 16.1% of profit before tax. Finance costs were ₹0.58 crore, or 0.3% of total income, and fell 4.9% YoY.
The notes say the company has entered into definitive agreements on 19 Oct 2026 with State Bank of India and NSE IFSC Limited to sell a 9.90% equity stake each in its wholly owned subsidiary CareEdge Global IFSC Limited. After completion the company's holding is to be 80.20%, and the subsidiary will cease to be wholly owned once closing actions and the share transfer approval by its Board are done. The results show no exceptional items for the quarter.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
150.41
126.81
+18.6%
103.79
+44.9%
Revenue from operations
134.21
114.27
+17.4%
88.16
+52.2%
Other income
16.20
12.54
+29.2%
15.63
+3.6%
69.16
55.83
+23.9%
33.88
+104.1%
Finance costs
0.35
0.40
-12.5%
0.37
-5.4%
Depreciation
2.33
2.30
+1.3%
2.33
0.0%
Tax expense
22.35
18.98
+17.8%
11.15
+100.4%
Net profit margin
45.98%
44.03%
+1.95 pp
32.64%
+13.34 pp
Tax as share of profit before tax
24.4%
25.4%
-0.95 pp
24.8%
-0.34 pp
EPS, basic (₹)
22.98
18.62
+23.4%
11.27
+103.9%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit of ₹69.16 crore rose 23.9% YoY, faster than standalone total income at 18.6%. Profit before tax was ₹91.51 crore and the tax expense of ₹22.35 crore is 24.4% of it, against 25.4% a year earlier.
Other income of ₹16.20 crore, up 29.2% YoY, is 17.7% of standalone profit before tax, while revenue from operations rose 17.4%. Consolidated net profit of ₹72.37 crore is ₹3.21 crore higher than the standalone figure.
The statutory auditor B S R & Co. LLP issued a limited review report with an unmodified conclusion on both the consolidated and standalone results. The notes record share based payment expenses of ₹58.83 lakh standalone and ₹73.11 lakh consolidated for the quarter, and 57,999 equity shares allotted on exercise of employee stock options during the quarter.
Inference
The Board declared an interim dividend of ₹10 per equity share of face value ₹10 for FY 2026-27, with 6 Nov 2026 as the record date, and says it will be paid within the timelines under the Companies Act, 2013. The total payout is not stated in the filing.
The Board also approved the appointment of Mr. Jatindar Pal Singh Bajaj as an Additional Director, designated Non-Executive Non-Independent Director, effective 29 Oct 2026, subject to shareholder approval.
The filing does not state the reason for selling the 9.90% stakes in CareEdge Global IFSC Limited, the consideration, or the date by which the sale is expected to complete.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
